Zeo ScientifiX Appoints New Directors, Board Shakeup
Ticker: ZEOX · Form: 8-K · Filed: Jun 3, 2024 · CIK: 1557376
Sentiment: neutral
Topics: board-composition, management-change
TL;DR
Zeo ScientifiX swapped out two board members, bringing in Smith and Galioto.
AI Summary
Zeo ScientifiX, Inc. announced on May 31, 2024, a change in its board of directors. The company elected two new directors, Mr. David L. Smith and Mr. Robert J. Galioto, to its board. This action was taken following the resignation of two previous directors, Mr. Robert L. Johnson and Mr. David L. Smith, from their positions.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting future business decisions and investor confidence.
Risk Assessment
Risk Level: low — The filing reports routine board changes without any indication of financial distress or significant operational shifts.
Key Players & Entities
- Zeo ScientifiX, Inc. (company) — Registrant
- David L. Smith (person) — Newly elected director
- Robert J. Galioto (person) — Newly elected director
- Robert L. Johnson (person) — Resigned director
FAQ
Who were the new directors appointed to Zeo ScientifiX's board?
Mr. David L. Smith and Mr. Robert J. Galioto were elected as new directors.
Who resigned from the board of directors at Zeo ScientifiX?
Mr. Robert L. Johnson and Mr. David L. Smith resigned from their positions on the board.
What is the exact date of the report for this 8-K filing?
The date of the report is May 31, 2024.
In which state was Zeo ScientifiX, Inc. incorporated?
Zeo ScientifiX, Inc. was incorporated in Nevada.
What was the previous name of Zeo ScientifiX, Inc.?
Zeo ScientifiX, Inc. was formerly known as Organicell Regenerative Medicine, Inc.
Filing Stats: 584 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-06-03 16:05:15
Filing Documents
- zeoscientifix_8k.htm (8-K) — 35KB
- 0001829126-24-003927.txt ( ) — 198KB
- ocel-20240531.xsd (EX-101.SCH) — 3KB
- ocel-20240531_lab.xml (EX-101.LAB) — 33KB
- ocel-20240531_pre.xml (EX-101.PRE) — 22KB
- zeoscientifix_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 3, 2024 ZEO SCIENTIFIX, INC. By: /s/ Ian T. Bothwell Ian T. Bothwell, Interim Chief Executive Officer and Chief Financial Officer 2